US pharma co denied patent on hepatitis C combo therapy

NEW DELHI: The Indian Patent Office has refused to grant a patent to US pharmaceutical firm AbbVie on its Hepatitis C combination therapy glecaprevir/pibrentasvir, marketed globally as Mavyret. The combination therapy is considered a key treatment for Hepatitis C, and the availability of affordable generic versions remains critical for widening patient access. “The order demonstrates…

Read More

CBI arrests coaching centre founder

PUNE/NEW DELHI: CBI arrested Shivraj Raghunath Motegaonkar, the director of Maharashtra-based Renukai Career Centre (RCC), alleging he circulated leaked NEETUG 2026 questions through coaching networks and “mock tests” conducted before examination, report Gitesh Shelke, Rajshekhar Jha & Koushiki Saha. This is the 10th arrest by CBI, which has now widened its probe, bringing more than…

Read More

India steps up ebola surveillance, preparedness after WHO emergency declaration

NEW DELHI: India has strengthened surveillance and preparedness measures at points of entry and across the public health system as a matter of “abundant caution” following the World Health Organization’s declaration of a Public Health Emergency of International Concern (PHEIC) over the Ebola outbreak in parts of Central Africa.Senior officials of the Union health ministry,…

Read More